Chapter 1.  TUBERCULOSIS DIAGNOSTICS MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.  TUBERCULOSIS DIAGNOSTICS MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3.  TUBERCULOSIS DIAGNOSTICS MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.  TUBERCULOSIS DIAGNOSTICS MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5.  TUBERCULOSIS DIAGNOSTICS MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6.  TUBERCULOSIS DIAGNOSTICS MARKET – by Diagnostic Test Type

6.1. Smear Microscopy

6.2. Culture Based Tests

6.3. Nucleic Acid Testing (NAT)

6.4. Radiographic Tests

6.5. Drug Susceptibility Testing (DST)

6.6. Serological Tests

6.7. IGRA (Interferon-Gamma Release Assays)

Chapter 7.  TUBERCULOSIS DIAGNOSTICS MARKET – By End User

7.1. Hospitals

7.2. Diagnostic Laboratories

7.3. Research and Academic Institutes

7.4. Others (Point of Care Testing and Home Healthcare)

Chapter 8.  TUBERCULOSIS DIAGNOSTICS MARKET – By Region

8.1. North America                           

8.2. Europe

8.3.The Asia Pacific

8.4.Latin America

8.5. Middle-East and Africa

Chapter 9.  TUBERCULOSIS DIAGNOSTICS MARKET  – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

9.1. Company 1

9.2. Company 2

9.3. Company 3

9.4. Company 4

9.5. Company 5

9.6. Company 6

9.7. Company 7

9.8. Company. 8

9.9. Company 9

9.10. Company 10